This study demonstrates that by inhibiting the sialic acid-SIGLEC-5/14 interaction, the effectiveness of CD11b/CD18-mediated neutrophil cytotoxic mechanism against tumor cells can be enhanced. The gene discussed is ITGB2; the disease is neoplasm.